2006
DOI: 10.1038/sj.tpj.6500386
|View full text |Cite
|
Sign up to set email alerts
|

Reference profiling of the genomic response induced by an antimicrotubule agent, TZT-1027 (Soblidotin), in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 35 publications
0
6
0
Order By: Relevance
“…The similarities and differences in mechanisms between classes of compounds sharing the same molecular target have been characterized using genomic profiling (7). In the present study, we used pharmacologic and genomic profiling in the CEPH cell lines to investigate two classes of Top1 inhibitors, the camptothecins and the indenoisoquinolines.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The similarities and differences in mechanisms between classes of compounds sharing the same molecular target have been characterized using genomic profiling (7). In the present study, we used pharmacologic and genomic profiling in the CEPH cell lines to investigate two classes of Top1 inhibitors, the camptothecins and the indenoisoquinolines.…”
Section: Discussionmentioning
confidence: 99%
“…Phosphorylation of histone H2AX is an extremely sensitive marker for double strand breaks induced by DNA damaging agents, such as the camptothecins and indenoisoquinolines (5, 6). It has been suggested that other histones are involved in DNA repair and cell proliferation (7). Studies indicate that histones are ADP-ribosylated in vivo in response to DNA damage (8).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…While clinical trials of dolastatin 10 have been terminated, several other dolastatin analogs are currently in clinical development (Flahive and Srirangam 2005) The synthetic derivative TZT-1027 (auristatin PE or soblidotin) is in Phase II clinical trials and has been shown to exhibit potent anti-vascular effects in addition to anti-tubulin activity, suggesting that a dual mechanism might well be possible with this agent (Shimoyama et al 2006). The analog cematodin (LU-103793) has progressed into Phase II clinical trials against malignant melanoma, metastatic breast cancer and non-small-cell lung cancer, and while no objective responses have been reported, there are reports of stable disease being seen in both the melanoma and breast cancer trials and a subjective increase in a quality of life measure in the lung trial (Flahive and Srirangam 2005).…”
Section: Some Marine-derived Anticancer Agentsmentioning
confidence: 99%
“…Sources of elevated ROS production include mitochondria and plasma membrane oxidase [17]. It has been reported that exposure to toxic core metals can induce high levels of ROS generation, which in turn can increase lipid peroxidation, reduce cell membrane integrity and result in oxidative damage to DNA and cellular proteins, leading to cell death [18][19][20].…”
Section: Introductionmentioning
confidence: 99%